Hearing aids

Studies of hearing aids in people

17 studies gave hearing aids to people and measured what changed

What changedDesignPeopleSource

no change: Has no effect on dementiaRR, 0.59; 95% CI, 0.25-1.38

up: Improves cognitive functionRR, 5.94; 95% CI, 2.46-14.37

Randomized trial24-month703 peopleBothmean 74.53 years, range 60-96 yearsOlder adults with MCIJAMA neurology, Sep 28, 2026

down: Decreases GFAPdifference: −0.175; 95% CI: −0.322, −0.028

no change: Has no effect on NfLdifference: −0.159; 95% CI: −0.348, 0.029

Randomized trial3 years977 peopleBoth70–84 yearsCommunity-dwelling older adultsEClinicalMedicine, Sep 3, 2026

down: Decreases glial fibrillary acidic proteinmean -0.415 (95% CI -0.712, -0.118)

down: Decreases NfLmean -0.349 (95% CI -0.652, -0.046)

no change: Has no effect on neurodegeneration blood biomarkers

Randomized trial3 years164 people70–84 yearsOlder adults; in ARIC participants with untreated hearing lossGSA 2025 abstract, Dec 31, 2025

no change: Has no effect on functional limitations

no change: Has no effect on activities of daily living

no change: Has no effect on instrumental activities of daily living

Randomized trial3 years977 peopleolder adultsOlder adultsGSA 2025 abstract, Dec 31, 2025

up: Increases 18F-FDG uptake

Trial12 months28 peopleBothmean age=77.4 yearsOlder adults; early compared to late hearing aid interventionAAIC 2025 abstract, Dec 25, 2025

down: Decreases fallsmean difference −0·54 (95% CI −0·77 to −0·31), 27% reduction

Randomized trial3 years977 people523 (54%) participants were female and 454 (46%) were male76·8 years (SD 4·0)Older adults with untreated hearing lossThe Lancet. Public health, May 30, 2025

down: Decreases cognitive decline61.6% reduction (95% CI: 33.7%–94.1%)

Randomized trialmedian follow-up time was 3.1 years (3.0, 3.2)977 people53.5% female76.8 yearsOlder adults with hearing loss and without cognitive impairmentAlzheimer's & dementia : the journal of the Alzheimer's Association, May 1, 2025

up: Improves cognitive function

down: Decreases NfL

Trialsix months50 peopleolder adultsPatients with age-related hearing loss and age- and sex-matched healthy controlsJournal of clinical medicine, Jan 21, 2025

no change: Has no effect on short Physical Performance Batteryβ=-0.001; 95%CI: -0.115, 0.113; p-value: 0.98

no change: Has no effect on grip strengthβ=0.016; 95%CI: -0.054, 0.085; p-value: 0.66

Randomized trial3-year977 peopleBothmean age of 76.8±4.0 yearsOlder adultsGSA 2024 abstract, Dec 31, 2024

up: Improves speech-in-noise performancebaseline 19.0 (16.0-22.5) to 21.3 at 2 months and 20.0 at 3 years

Randomized trial3-years220 peopleBothmedian age=75.5Older adults; Patient cohortsGSA 2024 abstract, Dec 31, 2024

down: Decreases cortical thinning

Randomized trial3 years445 peopleBoth70-84 yearsOlder adults; untreated hearing lossGSA 2024 abstract, Dec 31, 2024

up: Improves hearing Handicap Inventory-Elderly Screening version score

Randomized trial3 years923 people53.0% were femalemean age was 76.7 years (standard deviation (SD) = 4.0)Participants aged 70-84 years with adult-onset bilateral hearing loss, no current hearing aid use, and no substantial cognitive impairmentJournal of the American Geriatrics Society, Sep 12, 2024

no change: Has no effect on cognitive functionDifference 0·002 [95% CI: −0·077, 0·081]

down: Decreases cognitive decline-48%, Difference 0·191 [95% CI: 0·022, 0·360]

no change: Has no effect on cognitive impairmentHR 0·90 [95% CI: 0·61, 1·33]

Randomized trial3-year977 people53.5% femalemean age of 76·8 years (SD 4·0)Older adults aged 70 to 84 years with adult-onset bilateral hearing loss and free of substantial cognitive impairmentLancet (London, England), Jul 18, 2023

down: Decreases Hearing Handicap Inventory for the Elderlyactive −12.47 vs. sham −4.19, ES=1.05

no change: Has no effect on depressionactive −5.50 vs. sham - 7.32, ES=0.38

up: Improves cognitive functionactive +14.9 vs. sham +5.7, ES=0.62

Randomized trial12-week25 peopleaged ≥60 yearsOlder adults with comorbid HL and MDDThe American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry, Aug 14, 2021

up: Improves hearing functioningnp-ES = 0.62

up: Improves cognitive functionnp-ES = 0.25

up: Improves general functioningnp-ES = 0.53

Randomized trial12 weeks13 people≥60 yearsOlder adults; depressed older adults with age-related hearing lossInternational journal of geriatric psychiatry, Apr 16, 2020

up: Improves working memory

up: Increases cortical auditory evoked potentials

Trialsix monthsolder adultsOlder adults; first-time hearing aid users with age-related hearing loss, compared with hearing-matched controlsNeuropsychologia, May 2, 2018

up: Improves gait velocity20.5 cm/s higher gait velocity; five-point better Mini-BESTest score

Trial3 peopleadultMénière's disease; aided versus unaided conditionOtology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology, Feb 10, 2017